Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Intratumour heterogeneity frequently leads to drug resistance, which is a major issue in drug discovery. Drug distribution is one of the key factors for elucidating the resistance mechanism; however, quantitative and regional drug measurement is challenging. This service provides a ultra-sensitive analytical method which is applied it to HER3-targeting antibody–drug conjugate patritumab deruxtecan (HER3-DXd), aiming to explore its payload (DXd) distribution within heterogeneous tissues.